Share this:
An international group of vaccine researchers is proposing a comprehensive research plan to tackle the risks of the mosquito-borne Zika virus, now confirmed to cause birth defects. Dr. Gregory Poland, head of Mayo Clinic’s Vaccine Research Group and Editor in Chief of the journal Vaccine, has published an editorial with Ricardo Palacios and Jorge Kalil, both of the Butantan Institute, the largest biologics research center in Brazil.
The editorial – “Another emerging arbovirus, another emerging vaccine: Targeting Zika virus” – comes during the latest level of concern over Zika’s growing international risk and attempts to provide some accurate scientific background on the disease and its epidemiological history. Summary: It didn’t come out of nowhere – it has a track record.
Read more about the research editorial on Discovery's Edge.
Journalists: A broadcast quality sound bite with Dr. Poland and b-roll of him in the lab are in the downloads.
Share this:
Related articles
The Food and Drug Administration is expected to decide by Dec. 8 on a new therapy to treat sickle cell disease using gene editing technology called CRISPR, ...
ROCHESTER, Minn. — Patients who received the anticoagulant drug warfarin after bioprosthetic aortic valve replacement had lower incidence of mortality and a decreased risk of ...
DEAR MAYO CLINIC: My elderly mom has recently been told she needs to take a bunch of different medications every day due to her health ...